Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

How Bioinformatics is Boosting Precision Medicine

Posted on January 9th, 2017 by in Pharma R&D


Although the pharmaceutical industry has invested a great deal in data-producing technologies (e.g. next-generation and single cell sequencing), it has been slower to invest in the data management and analytics technologies that are needed to actually draw insights and information from all that data. Areas where these important investments in management have been made, however, are starting to see some noteworthy results.

For instance, bioinformatics tools are already helping R&D teams quickly mine data from literature that helps them repurpose drugs to treat the sorts of rare diseases that affect millions of people but have historically gone ignored. Bioinformatics solutions, which can include tools like natural language processing software, are also being successfully utilized to accelerate immunotherapy development and to improve microbiome analyses.

Read this article to find out more about how bioinformatics, such as the burgeoning field of translational bioinformatics, will continue driving precision medicine into the future.


All opinions shared in this post are the author’s own.

R&D Solutions for Pharma & Life Sciences

We're happy to discuss your needs and show you how Elsevier's Solution can help.

Contact Sales